Agios Pharmaceuticals IncのRSI
Agios Pharmaceuticals IncのRSIは何ですか。
Agios Pharmaceuticals IncのRSIは44.96です。
RSIの定義は何ですか。
相対力指数 (The relative strength index, RSI 14)は、一定期間における損益の規模を比較して、証券の価格変動の速度と変動を測る指標です。
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
NASDAQのセクタHealth CareにおけるRSIの企業と比べるAgios Pharmaceuticals Inc
Agios Pharmaceuticals Incは何をしますか。
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Agios Pharmaceuticals Incと類似のrsi
- Toscana IncomeのRSIは44.95です。
- Middle Island ResourcesのRSIは44.95です。
- ITT IncのRSIは44.95です。
- Maithan AlloysのRSIは44.95です。
- U.S. Gold CorpのRSIは44.95です。
- Stitch Fix IncのRSIは44.95です。
- Agios Pharmaceuticals IncのRSIは44.96です。
- Clean TeQのRSIは44.97です。
- Kesselrun ResourcesのRSIは44.97です。
- Cerence IncのRSIは44.97です。
- TEB IncのRSIは44.97です。
- Marvell TechnologyのRSIは44.97です。
- IWG PlcのRSIは44.97です。